AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30585337 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (ALA) 1200 mg plus 400 mg vitamin E
Number of subjects: 50
Study 30585337 — intervention group
Group type: COMPARATOR
Intervention: Placebo (starch) plus 400 mg vitamin E
Number of subjects: 50
Study 28248869 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (100% fatty acid component with 12.5% CMO)
Number of subjects: 28
Study 28248869 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (80% fatty acid component with 12.5% CMO)
Number of subjects: 28
Study 28248869 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (62.4% fatty acid component with 12.5% CMO)
Number of subjects: 28
Study 28248869 — intervention group
Group type: COMPARATOR
Intervention: Control Group D (starch 100%)
Number of subjects: 28
Study 25955349 — intervention group
Group type: EXPERIMENTAL
Intervention: CHX‐MW (0.2% CHX mouthwash)
Number of subjects: 201
Study 25955349 — intervention group
Group type: COMPARATOR
Intervention: CONTROL (no prophylaxis)
Number of subjects: 201
Study 25955349 — intervention group
Group type: EXPERIMENTAL
Intervention: CHX‐MW/SUB_IR (0.2% CHX mouthwash and 1% CHX subgingival irrigation)
Number of subjects: 201
Study 25955349 — intervention group
Group type: EXPERIMENTAL
Intervention: CHX‐MW/SUPRA_IR (0.2% CHX mouthwash and 1% CHX supragingival irrigation)
Number of subjects: 201
Study 23837415 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Centered Disease Management (PCDM) intervention including collaborative care management by VA clinicians, home telemonitoring, guided patient self-management support, and screening and treatment for comorbid depression.
Number of subjects: 0
Study 23837415 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study 23837415 — intervention group
Group type: EXPERIMENTAL
Intervention: PCDM intervention
Number of subjects: 0
Study 21081229 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 0
Study 21081229 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 0
Study 21081229 — intervention group
Group type: COMPARATOR
Intervention: Combination of aerobic and resistance exercise
Number of subjects: 0
Study 21081229 — intervention group
Group type: COMPARATOR
Intervention: No exercise
Number of subjects: 0
Study 19379588 — intervention group
Group type: EXPERIMENTAL
Intervention: CHG regimen (homoharringtonine, cytarabine, G-CSF)
Number of subjects: 30
Study 19379588 — intervention group
Group type: COMPARATOR
Intervention: CAG regimen (aclarubicin/Ara-C, G-CSF)
Number of subjects: 30
Study 19379588 — intervention group
Group type: COMPARATOR
Intervention: HA regimen (HHT/Ara-C, G-CSF)
Number of subjects: 30
Study 17321919 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 70
Study 17321919 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 70
Study 15342154 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-based estimation using a rigid trunk model
Number of subjects: 5
Study 15342154 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-based estimation using a segmented trunk model
Number of subjects: 5
Study 15342154 — intervention group
Group type: COMPARATOR
Intervention: Position and force data method (control)
Number of subjects: 5
Study 11176553 — intervention group
Group type: EXPERIMENTAL
Intervention: One-to-one education
Number of subjects: 595
Study 11176553 — intervention group
Group type: EXPERIMENTAL
Intervention: Group education
Number of subjects: 595
Study 11176553 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 595
Study 11176553 — intervention group
Group type: EXPERIMENTAL
Intervention: One-to-one education with reminders
Number of subjects: 595
Study 10633736 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention on the nursing process and documentation according to the VIPS model
Number of subjects: 120
Study 10633736 — intervention group
Group type: COMPARATOR
Intervention: Reference group (no intervention)
Number of subjects: 120
Study 7802307 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (75 micrograms) and Morphine (0.5 mg)
Number of subjects: 90
Study 7802307 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (0.5 mg)
Number of subjects: 90
Study 7802307 — intervention group
Group type: COMPARATOR
Intervention: 0.9% Sodium Chloride (Control)
Number of subjects: 90
Study 2312234 — intervention group
Group type: EXPERIMENTAL
Intervention: Third- and fourth-year student nurses and registered nurses
Number of subjects: 24
Study 2312234 — intervention group
Group type: EXPERIMENTAL
Intervention: Third- and fourth-year student nurses
Number of subjects: 24
Study 2312234 — intervention group
Group type: COMPARATOR
Intervention: First-year student nurses
Number of subjects: 24
Study 2312234 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses with nursing experience
Number of subjects: 24
Study 2312234 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses assessing patients with physical pathology
Number of subjects: 24
Study 7001044 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine gel
Number of subjects: 50
Study 7001044 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 50
Study 30367470 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexitheralight protocol (n = 156 AKs)
Number of subjects: 25
Study 30367470 — intervention group
Group type: COMPARATOR
Intervention: Conventional protocol (Aktilite CL 128 lamp) (n = 154 AKs)
Number of subjects: 25
Study 30367470 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexitheralight protocol
Number of subjects: 25
Study 30367470 — intervention group
Group type: COMPARATOR
Intervention: Conventional protocol (Aktilite CL 128 lamp)
Number of subjects: 25
Study 27463536 — intervention group
Group type: EXPERIMENTAL
Intervention: Inform Me mobile Web application after routine transplant education
Number of subjects: 288
Study 27463536 — intervention group
Group type: COMPARATOR
Intervention: Routine transplant education alone
Number of subjects: 288
Study 24548259 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid energy intake (1 MJ day(-1))
Number of subjects: 158
Study 24548259 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid energy intake
Number of subjects: 158
Study 24548259 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-sweetened beverages (SSB) consumption (100 g day(-1))
Number of subjects: 158
Study 24548259 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet drinks (100 g day(-1))
Number of subjects: 158
Study 24548259 — intervention group
Group type: EXPERIMENTAL
Intervention: Substitution of 100 g of SSB by 100 g of water or diet drink
Number of subjects: 158
Study 23706327 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate ≥70 bpm
Number of subjects: 18980
Study 23706327 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate as a continuous variable
Number of subjects: 18980
Study 21718836 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte filtration (LF)
Number of subjects: 60
Study 19938555 — intervention group
Group type: EXPERIMENTAL
Intervention: Bushen Jianpi Huoxue Paidu
Number of subjects: 0
Study 17966760 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyme-primrose combination (1 tablet three times daily for 11 days)
Number of subjects: 361
Study 17966760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 361
Study 17966760 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyme-primrose combination
Number of subjects: 361
Study 17966760 — intervention group
Group type: COMPARATOR
Intervention: Thyme-primrose combination and Placebo
Number of subjects: 361
Study 15194515 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Psychotherapy and Home‐Based Physical Exercise (GROUP‐HOPE)
Number of subjects: 51
Study 11435811 — intervention group
Group type: EXPERIMENTAL
Intervention: P13-like potentials after P11 with noncephalic reference
Number of subjects: 5
Study 11435811 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed true P13/14s followed by N18s
Number of subjects: 5
Study 11435811 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower cervical P13 (lcP13)
Number of subjects: 5
Study 11669215 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony‐stimulating factor (G‐CSF)‐stimulated peripheral blood mononuclear cells (GPBMC)
Number of subjects: 0
Study 11669215 — intervention group
Group type: COMPARATOR
Intervention: Bone marrow (BM)
Number of subjects: 0
Study 9422416 — intervention group
Group type: EXPERIMENTAL
Intervention: TAC-MMF
Number of subjects: 71
Study 9422416 — intervention group
Group type: COMPARATOR
Intervention: CsA-MMF
Number of subjects: 71
Study 8487122 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care brochures
Number of subjects: 14917
Study 3112024 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudomonas hyperimmune globulin (n = 15)
Number of subjects: 30
Study 3112024 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 30
Study 2102067 — intervention group
Group type: EXPERIMENTAL
Intervention: PDRN 1.65 mg vaginal suppositories
Number of subjects: 40
Study 2102067 — intervention group
Group type: EXPERIMENTAL
Intervention: PDRN 5 mg vaginal suppositories
Number of subjects: 40
Study 2102067 — intervention group
Group type: COMPARATOR
Intervention: PDRN (both dosages)
Number of subjects: 40
Study 238429 — intervention group
Group type: EXPERIMENTAL
Intervention: Midline incision
Number of subjects: 48
Study 238429 — intervention group
Group type: COMPARATOR
Intervention: Transverse incision
Number of subjects: 48
Study 31275442 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating levels of miR-574-5p measured by quantitative PCR in plasma samples collected 48 hours after cardiac arrest.
Number of subjects: 590
Study 31275442 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating levels of miR-574-5p after adjustment with clinical variables and NSE.
Number of subjects: 590
Study 28931166 — intervention group
Group type: EXPERIMENTAL
Intervention: Harvest of the Month (HOTM) program
Number of subjects: 275
Study 28931166 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual practice)
Number of subjects: 275
Study 26012585 — intervention group
Group type: EXPERIMENTAL
Intervention: STEEP-b plus treatment as usual (TAU)
Number of subjects: 120
Study 26012585 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 120
Study 25349392 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrimination of fearful and nonfearful eyes
Number of subjects: 0
Study 25349392 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrimination of direct and averted gaze
Number of subjects: 0
Study 25349392 — intervention group
Group type: EXPERIMENTAL
Intervention: Response to human sclera
Number of subjects: 0
Study 22595313 — intervention group
Group type: EXPERIMENTAL
Intervention: secukinumab (2×10 mg/kg intravenous)
Number of subjects: 59
Study 22595313 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 59
Study 22595313 — intervention group
Group type: EXPERIMENTAL
Intervention: secukinumab
Number of subjects: 59
Study 20013559 — intervention group
Group type: EXPERIMENTAL
Intervention: High glycemic index meal (HGI, GI=77)
Number of subjects: 7
Study 20013559 — intervention group
Group type: COMPARATOR
Intervention: Low glycemic index meal (LGI, GI=37)
Number of subjects: 7
Study 17304885 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib
Number of subjects: 37
Study 15347716 — intervention group
Group type: EXPERIMENTAL
Intervention: SUV (Standardized Uptake Value)
Number of subjects: 33
Study 15347716 — intervention group
Group type: EXPERIMENTAL
Intervention: KPat (Fluoride bone influx rate obtained by Patlak analysis)
Number of subjects: 33
Study 15347716 — intervention group
Group type: EXPERIMENTAL
Intervention: KNLR (Fluoride bone influx rate obtained by nonlinear regression)
Number of subjects: 33
Study 15347716 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in metabolic values of the grafts for KPat and KNLR
Number of subjects: 33
Study 15347716 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in metabolic values of the grafts for KPat and SUV
Number of subjects: 33
Study 15347716 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in metabolic values of the grafts for KNLR and SUV
Number of subjects: 33
Study 15347716 — intervention group
Group type: EXPERIMENTAL
Intervention: 95% range of normal change in limb bones for SUV
Number of subjects: 33
Study 15347716 — intervention group
Group type: EXPERIMENTAL
Intervention: 95% range of normal change in limb bones for KPat
Number of subjects: 33
Study 15347716 — intervention group
Group type: EXPERIMENTAL
Intervention: 95% range of normal change in limb bones for KNLR
Number of subjects: 33
Study 15347716 — intervention group
Group type: EXPERIMENTAL
Intervention: 95% range of normal change in spine for SUV
Number of subjects: 33
Study 15347716 — intervention group
Group type: EXPERIMENTAL
Intervention: 95% range of normal change in spine for KPat
Number of subjects: 33
Study 15347716 — intervention group
Group type: EXPERIMENTAL
Intervention: 95% range of normal change in spine for KNLR
Number of subjects: 33
Study 12040215 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteogenic device (OD)
Number of subjects: 13
Study 12040215 — intervention group
Group type: COMPARATOR
Intervention: Autologous bone grafts (ABGs)
Number of subjects: 13
Study 9810576 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR TKA
Number of subjects: 57
Study 9810576 — intervention group
Group type: EXPERIMENTAL
Intervention: PS TKA
Number of subjects: 57
Study 9810576 — intervention group
Group type: EXPERIMENTAL
Intervention: ACLD knee
Number of subjects: 57
Study 9810576 — intervention group
Group type: COMPARATOR
Intervention: Normal knee
Number of subjects: 57
Study 9810576 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated walking conditions
Number of subjects: 57
Study 9810576 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum separation in PCR knee
Number of subjects: 57
Study 9810576 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellofemoral impact force
Number of subjects: 57
Study 7759676 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral and cognitive-behavioral therapy methods
Number of subjects: 0
Study 7759676 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific, focused therapy methods
Number of subjects: 0
Study 7759676 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured therapy with treatment manuals and monitoring
Number of subjects: 0
Study 2539203 — intervention group
Group type: EXPERIMENTAL
Intervention: Efamol (evening primrose oil containing gamma-linolenic acid, with vitamin E as preservative) - 8 capsules per day
Number of subjects: 18
Study 2539203 — intervention group
Group type: EXPERIMENTAL
Intervention: D-amphetamine
Number of subjects: 18
Study 2539203 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 190671 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride dentifrice
Number of subjects: 400
Study 190671 — intervention group
Group type: COMPARATOR
Intervention: Sodium monofluorophosphate dentifrice
Number of subjects: 400
Study 31653400 — intervention group
Group type: EXPERIMENTAL
Intervention: Gold alloy against rough-surface zirconia
Number of subjects: 60
Study 31653400 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-Cr alloy against smooth-surface zirconia
Number of subjects: 60
Study 31653400 — intervention group
Group type: COMPARATOR
Intervention: Rough-surface monolithic zirconia
Number of subjects: 60
Study 30485425 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibition of arginine metabolism
Number of subjects: 0
Study 30485425 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of plasma arginine concentrations
Number of subjects: 0
Study 28260986 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning (RIPC)
Number of subjects: 72
Study 28260986 — intervention group
Group type: COMPARATOR
Intervention: Control group (no RIPC)
Number of subjects: 72
Study 25757593 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg/d pure hesperidin supplement
Number of subjects: 75
Study 25757593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 23497761 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl Sublingual Spray (FSS) 400 μg
Number of subjects: 29
Study 23497761 — intervention group
Group type: COMPARATOR
Intervention: Oral Transmucosal Fentanyl Citrate (OTFC) 400 μg
Number of subjects: 29
Study 23497761 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Fentanyl Citrate 100 μg
Number of subjects: 29
Study 22439299 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirituality Teaching Program Group (8 week, home‐based Spirituality Teaching Program)
Number of subjects: 84
Study 22439299 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control Group (no intervention followed by Spirituality Teaching Program starting at week 9)
Number of subjects: 84
Study 19699472 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolcapone (200 mg)
Number of subjects: 25
Study 19699472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 16879763 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 479
Study 14767306 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia program (group 1)
Number of subjects: 60
Study 14767306 — intervention group
Group type: COMPARATOR
Intervention: Standard lecture (group 2)
Number of subjects: 60
Study 11593078 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate, sustained-release capsules (15 to 30 mg initially, increased to 30 mg or 60 mg at week 5)
Number of subjects: 128
Study 11593078 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate, sustained-release capsules (30 to 60 mg)
Number of subjects: 128
Study 11593078 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 128
Study 9647058 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent antegrade tepid blood cardioplegia (29 degrees C)
Number of subjects: 52
Study 9647058 — intervention group
Group type: COMPARATOR
Intervention: Cold blood cardioplegia (4 degrees C)
Number of subjects: 52
Study 7915845 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipsapirone 5.0mg tid
Number of subjects: 267
Study 7915845 — intervention group
Group type: COMPARATOR
Intervention: Ipsapirone 2.5mg tid
Number of subjects: 267
Study 7915845 — intervention group
Group type: COMPARATOR
Intervention: Ipsapirone 7.5mg tid
Number of subjects: 267
Study 7915845 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study 2513050 — intervention group
Group type: EXPERIMENTAL
Intervention: Four meals a day including a late evening meal (2300)
Number of subjects: 9
Study 2513050 — intervention group
Group type: EXPERIMENTAL
Intervention: Six meals a day including a late evening meal (2300)
Number of subjects: 9
Study 2513050 — intervention group
Group type: COMPARATOR
Intervention: Three meals a day
Number of subjects: 9
Study 4427449 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% grade treadmill running
Number of subjects: 7
Study 4427449 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.0% grade treadmill running
Number of subjects: 7
Study 4427449 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% grade treadmill running
Number of subjects: 7
Study 4427449 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive treadmill running
Number of subjects: 7
Study 31574108 — intervention group
Group type: EXPERIMENTAL
Intervention: Badminton training course for 12 weeks
Number of subjects: 2
Study 31574108 — intervention group
Group type: COMPARATOR
Intervention: Control group (no regular ball sports during the period)
Number of subjects: 2
Study 30180273 — intervention group
Group type: EXPERIMENTAL
Intervention: CaCO3 1200 mg/day with 10,000 IU vitamin D3/day
Number of subjects: 48
Study 30180273 — intervention group
Group type: COMPARATOR
Intervention: CaCO3 1200 mg/day with 600 IU vitamin D3/day
Number of subjects: 48
Study 26654135 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ondansetron (n = 85)
Number of subjects: 170
Study 26654135 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 85)
Number of subjects: 170
Study 24485947 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective communication during bad news consultation
Number of subjects: 50
Study 24485947 — intervention group
Group type: COMPARATOR
Intervention: Standard communication during bad news consultation
Number of subjects: 50
Study 22302704 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude extracts from Commiphora swynnertonii (various concentrations)
Number of subjects: 6
Study 22302704 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude extracts from Commiphora swynnertonii (500 μg/mL resin extract)
Number of subjects: 6
Study 22302704 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude extracts from Commiphora swynnertonii (resin and root bark extracts)
Number of subjects: 6
Study 22302704 — intervention group
Group type: COMPARATOR
Intervention: Positive control (inoculated with NDV without treatment)
Number of subjects: 6
Study 19150495 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil containing 3.7 g/day n‐3 polyunsaturated fatty acid (n‐3PUFA)
Number of subjects: 83
Study 19150495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 19150495 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil containing 3.7 g/day n‐3PUFA
Number of subjects: 83
Study 17229227 — intervention group
Group type: EXPERIMENTAL
Intervention: NSCF during intubation
Number of subjects: 20
Study 17229227 — intervention group
Group type: EXPERIMENTAL
Intervention: RE-Delta during intubation
Number of subjects: 20
Study 17229227 — intervention group
Group type: EXPERIMENTAL
Intervention: NSCF pre-stimuli vs post-stimuli during tetanic stimulation
Number of subjects: 20
Study 17229227 — intervention group
Group type: COMPARATOR
Intervention: NSCF R+ vs R- during tetanic stimulation
Number of subjects: 20
Study 17229227 — intervention group
Group type: EXPERIMENTAL
Intervention: RE-Delta during tetanic stimulation
Number of subjects: 20
Study 17229227 — intervention group
Group type: EXPERIMENTAL
Intervention: RE during emergence
Number of subjects: 20
Study 14745054 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral pallidotomy
Number of subjects: 34
Study 14745054 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral STN stimulation
Number of subjects: 34
Study 11668094 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard information (diagnosis, circumstances surrounding injury, and disposal)
Number of subjects: 0